Haleon (HLN) Cash from Operations (2022)

Haleon (HLN) posted Cash from Operations of 10803842766.01 for Q4 2022, up 4.74% on a QoQ basis from 11341458482.44 in Q3 2022.

Haleon (HLN) Cash from Operations (2022) Analysis & Trends

Haleon's Cash from Operations history runs 1 years deep, the most recent figure standing at 10803842766.01 for Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Operations (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	-40.00 Mn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	401.00 Mn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	1.58 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	463.30 Mn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	388.30 Mn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	145.80 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	13.00 Mn
10	Vireo Growth	10.57 Bn	10.41 Bn	59.30 Mn	11.90 Mn

Download Data